The molecular basis of dietary fatty acid regulation of gene expression has gained considerable attention in recent years because of its contribution to chronic disease [obesity, diabetes &atherosclerosis]: Our studies have focused on dietary polyunsaturated fatty acid (PUFA: eicosapentaenoic acid [20:5n3] and docosahexaneoic acid [22:6n3]) control of three hepatic transcription factors, sterol regulatory element binding protein (SREBP-1c), peroxisome proliferator activated receptor (PPARalpha) and liver X receptor (LXRalpha). These studies have revealed new information on: a) dynamic &cell-specific PUFA regulation of each transcription factor;b) developmental regulation of SREBP-1c and its regulatory network, and c) a role for PPARalpha and SREBP-1 in PUFA synthesis;d) the regulation of fatty acid elongases &desaturases;e) induction of these enzymes generates fatty acids that do not normally accumulate in cells;these rare fatty acids impact cell signaling by affecting eicosanoid production. These findings have broad implications for metabolic regulation, particularly with regard to chronic diseases like diabetes, obesity and atherosclerosis, where clinical data links fatty acid metabolites to disease progression. There remains a poor understanding of the role fatty acid elongases play in hepatic and whole body physiology. We hypothesize that hepatic fatty acid elongation: a) regulates hepatic &extrahepatic (aortic and blood) fatty acid composition;b)/egulates key transcription factors [PPARalpha &SREBP-1 c];and c) influences the onset or progression of chronic disease, e.g., diabetes, obesity or atherosclerosis.
The specific aims are to: 1. Define the metabolic regulation of hepatic fatty acid elongases;2. Define the role of PPARalpha and SREBP-1 in the regulation of fatty acid elongases;3. Define the effects of fatty acid elongases on hepatocyte lipid composition and gene expression;4. Determine how over expression of specific fatty acid elongases affects hepatic function, blood lipid composition and the onset of chronic disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK043220-17
Application #
7585763
Study Section
Integrative Nutrition and Metabolic Processes Study Section (INMP)
Program Officer
Maruvada, Padma
Project Start
1991-08-01
Project End
2011-03-31
Budget Start
2009-04-01
Budget End
2011-03-31
Support Year
17
Fiscal Year
2009
Total Cost
$298,874
Indirect Cost
Name
Oregon State University
Department
Nutrition
Type
Other Domestic Higher Education
DUNS #
053599908
City
Corvallis
State
OR
Country
United States
Zip Code
97339
Jump, Donald B; Depner, Christopher M; Tripathy, Sasmita et al. (2016) Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice. Proc Nutr Soc 75:1-9
Lytle, Kelli A; Depner, Christopher M; Wong, Carmen P et al. (2015) Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGF?-Smad3 pathway. J Lipid Res 56:1936-46
Tripathy, Sasmita; Lytle, Kelli A; Stevens, Robert D et al. (2014) Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice. J Lipid Res 55:1448-64
Tripathy, Sasmita; Jump, Donald B (2013) Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice. J Lipid Res 54:71-84
Depner, Christopher M; Torres-Gonzalez, Moises; Tripathy, Sasmita et al. (2012) Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice. J Nutr 142:1495-503
Jump, Donald B (2011) Fatty acid regulation of hepatic lipid metabolism. Curr Opin Clin Nutr Metab Care 14:115-20
Jump, Donald B; Torres-Gonzalez, Moises; Olson, L Karl (2011) Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation. Biochem Pharmacol 81:649-60
Lebold, Katie M; Jump, Donald B; Miller, Galen W et al. (2011) Vitamin E deficiency decreases long-chain PUFA in zebrafish (Danio rerio). J Nutr 141:2113-8
Tikhonenko, Maria; Lydic, Todd A; Wang, Yun et al. (2010) Remodeling of retinal Fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4. Diabetes 59:219-27
Tripathy, Sasmita; Torres-Gonzalez, Moises; Jump, Donald B (2010) Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese C57BL/6J mice. J Lipid Res 51:2642-54

Showing the most recent 10 out of 53 publications